Get the Stockscreener App
26.88
18.52%
4.20
After Hours:
26.89
0.01
+0.04%
Agilon Health Inc stock is traded at $26.88, with a volume of 329.93K.
It is up +18.52% in the last 24 hours and up +79.20% over the past month.
Agilon Health Inc is a healthcare services company that partners with primary care physicians to support value-based care for senior patients. The company provides a platform that enables physician groups to manage healthcare outcomes and costs through a Medicare-centric, capitated care model and long-term partnerships with community-based physicians.
See More
Previous Close:
$22.68
Open:
$22.31
24h Volume:
329.93K
Relative Volume:
1.11
Market Cap:
$446.37M
Revenue:
$5.93B
Net Income/Loss:
$-405.35M
P/E Ratio:
-1.1041
EPS:
-24.3461
Net Cash Flow:
$-148.87M
1W Performance:
+45.53%
1M Performance:
+79.20%
6M Performance:
+5.41%
1Y Performance:
-80.56%
1-Day Range:
$21.89
$27.00
1-Week Range:
$16.54
$27.00
52-Week Range:
$7.48
$141.00
Agilon Health Inc Stock (AGL) Company Profile
Name
Agilon Health Inc
Sector
Industry
Phone
562-256-3800
Address
440 POLARIS PARKWAY, WESTERVILLE
Compare AGL vs HCA, THC, FMS, ENSG, UHS
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AGL
Agilon Health Inc
|
26.88 | 376.62M | 5.93B | -405.35M | -148.87M | -24.35 |
HCA
Hca Healthcare Inc
|
488.58 | 111.48B | 75.60B | 7.78B | 7.69B | 28.38 |
THC
Tenet Healthcare Corp
|
193.56 | 17.10B | 21.31B | 2.37B | 2.53B | 15.49 |
FMS
Fresenius Medical Care Ag Adr
|
22.84 | 12.68B | 22.18B | 1.36B | 2.00B | 1.9216 |
ENSG
Ensign Group Inc
|
197.92 | 11.59B | 5.06B | 344.26M | 370.71M | 5.8446 |
UHS
Universal Health Services Inc
|
180.15 | 11.10B | 17.36B | 1.51B | 849.25M | 23.15 |
Agilon Health Inc Stock (AGL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-20-25 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Aug-06-25 | Downgrade | Citigroup | Buy → Neutral |
| Apr-25-25 | Upgrade | Citigroup | Neutral → Buy |
| Apr-08-25 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Jan-10-25 | Upgrade | Citigroup | Sell → Neutral |
| Jan-10-25 | Initiated | Needham | Hold |
| Dec-16-24 | Initiated | Macquarie | Neutral |
| Dec-11-24 | Initiated | Bernstein | Mkt Perform |
| Nov-11-24 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Nov-08-24 | Downgrade | William Blair | Outperform → Mkt Perform |
| Oct-30-24 | Downgrade | Citigroup | Neutral → Sell |
| Oct-02-24 | Downgrade | BofA Securities | Buy → Underperform |
| May-30-24 | Initiated | Robert W. Baird | Neutral |
| Apr-22-24 | Initiated | Citigroup | Neutral |
| Mar-06-24 | Initiated | Barclays | Underweight |
| Feb-26-24 | Downgrade | Jefferies | Buy → Hold |
| Feb-26-24 | Downgrade | TD Cowen | Outperform → Market Perform |
| Jan-08-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Jan-08-24 | Downgrade | Stifel | Buy → Hold |
| Jan-08-24 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jan-05-24 | Downgrade | JP Morgan | Overweight → Neutral |
| Jan-05-24 | Downgrade | Truist | Buy → Hold |
| Dec-11-23 | Downgrade | Goldman | Buy → Neutral |
| Dec-06-23 | Initiated | JMP Securities | Mkt Outperform |
| Nov-21-23 | Downgrade | Deutsche Bank | Buy → Hold |
| Oct-20-23 | Initiated | The Benchmark Company | Buy |
| Jun-13-23 | Initiated | Evercore ISI | In-line |
| Dec-09-22 | Initiated | Stifel | Buy |
| Sep-14-22 | Initiated | RBC Capital Mkts | Outperform |
| Sep-12-22 | Initiated | Goldman | Buy |
| Sep-07-22 | Resumed | Truist | Buy |
| Jun-24-22 | Initiated | BTIG Research | Neutral |
| Mar-30-22 | Initiated | Guggenheim | Buy |
| Oct-20-21 | Initiated | Jefferies | Buy |
| Sep-27-21 | Initiated | SVB Leerink | Outperform |
| Sep-10-21 | Initiated | Cowen | Outperform |
| May-11-21 | Initiated | William Blair | Outperform |
| May-10-21 | Initiated | BofA Securities | Buy |
| May-10-21 | Initiated | Deutsche Bank | Buy |
| May-10-21 | Initiated | Goldman | Buy |
| May-10-21 | Initiated | JP Morgan | Overweight |
| May-10-21 | Initiated | Truist | Buy |
| May-10-21 | Initiated | Wells Fargo | Overweight |
| May-10-21 | Initiated | Wolfe Research | Outperform |
View All
Agilon Health Inc Stock (AGL) Latest News
Outpatient & Specialty Care Stocks Q4 Recap: Benchmarking agilon health (NYSE:AGL) - Yahoo Finance
Why Agilon Health (AGL) is doing a 1-for-25 reverse split to stay NYSE-compliant - MSN
agilon health inc stock (US00857U1079): Why its total cost of care model matters more now for invest - AD HOC NEWS
Agilon Health (AGL) price target increased by 2,183.69% to 21.99 - MSN
Big Picture: What is the Moat Score of agilon health incWeekly Profit Analysis & Community Verified Trade Signals - baoquankhu1.vn
agilon health (AGL) Price Target Decreased by 25.00% to 1.07 - MSN
Bernstein maintains agilon health stock rating, cites 2026 outlook By Investing.com - Investing.com India
Bernstein maintains agilon health stock rating, cites 2026 outlook - Investing.com
Did agilon health, inc. Insiders Breach their Fiduciary Duties t - GuruFocus
Did agilon health, inc. Insiders Breach their Fiduciary Duties to Shareholders? - ChartMill
AGL Stock Price, Quote & Chart | AGILON HEALTH INC (NYSE:AGL) - ChartMill
AGL Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Value Recap: Is agilon health inc currently under institutional pressure2026 Levels & Long-Term Growth Plans - baoquankhu1.vn
Published on: 2026-04-08 05:19:06 - baoquankhu1.vn
Astrana Health, Evolent Health, Neogen, agilon health, and Fortrea Shares Are Soaring, What You Need To Know - Yahoo Finance
Key facts: Agilon Health up 13.6% after Medicare rate hike; Q1 May 6 - TradingView — Track All Markets
agilon health Sets Date to Report Q1 2026 Earnings - National Today
agilon health Sets Date to Report First Quarter 2026 Financial Results - National Today
Agilon Health (AGL) Soars 25% in Intraday Surge: What’s Driving This Volatile Rally? - Bitget
If You Invested $1,000 in Agilon Health Inc (AGL) - Stock Titan
agilon health (AGL) CFO receives 75,000 RSUs after reverse stock split - Stock Titan
agilon health (AGL) CMO granted 70,000 RSUs, holdings now 123,525 shares - Stock Titan
agilon health (AGL) CAO gets 10,000 RSUs, 266 shares withheld for taxes - Stock Titan
agilon health (AGL) CTO receives 28,000-share RSU grant and tax withholding entry - Stock Titan
[Form 4] agilon health, inc. Insider Trading Activity - Stock Titan
agilon health inc stock: Reverse Split Sparks Analyst Optimism - AD HOC NEWS
AGL Analyst Rating Update: Benchmark Raises Price Target by 766. - gurufocus.com
Agilon Health (NYSE:AGL) Stock Price Expected to Rise, Benchmark Analyst Says - marketbeat.com
Benchmark raises agilon health stock price target on reverse split By Investing.com - Investing.com Canada
Benchmark Co. Maintains Agilon Health(AGL.US) With Buy Rating, Cuts Target Price to $13 - Moomoo
Benchmark raises agilon health stock price target on reverse split - Investing.com
Agilon Health (NYSE:AGL) Shares Up 9.3%Should You Buy? - MarketBeat
Investor Notice: Robbins LLP Informs Investors of the Agilon Health, Inc. Securities Class Action - The National Law Review
Agilon Health Enacts 1-for-25 Reverse Stock Split - The Globe and Mail
Agilon Health (NYSE:AGL) Hits New 52-Week LowTime to Sell? - MarketBeat
AGILON HEALTH STOCKHOLDER ALERT: Kaskela Law Firm Announces - GlobeNewswire
Agilon Health enacts 1-for-25 reverse stock split, trading to begin Tuesday - Investing.com UK
Agilon Health enacts 1-for-25 reverse stock split, trading to begin Tuesday By Investing.com - Investing.com South Africa
1-for-25 reverse split reshapes agilon health (NYSE: AGL) share count - Stock Titan
Aug Outlook: Is agilon health inc forming a double bottomEarnings Growth Report & Community Supported Trade Ideas - baoquankhu1.vn
Agilon Health outlines $5.5B revenue and breakeven adjusted EBITDA for 2026 amid transformation and disciplined contracting - MSN
Why agilon health (AGL) Is Doing a 1-for-25 Reverse Split to Stay NYSE-Compliant - Yahoo Finance
5 Penny Stocks with Potential to Rise 1000 Percent - Insider Monkey
Agilon Health (AGL) Receives a Sell from Barclays - theglobeandmail.com
agilon health inc stock faces pressure from 7.6% drop amid cost concerns and looming 1-for-10 revers - AD HOC NEWS
Agilon Health Inc Stock (AGL) Financials Data
Revenue
Net Income
Cash Flow
EPS
Agilon Health Inc Stock (AGL) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Wulf John William | Director |
Nov 12 '25 |
Buy |
0.63 |
81,000 |
50,941 |
365,857 |
1.58%
3.27%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):